Clinical Trial

Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

Name: Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors — clinical trial record (NCT07282873)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study is to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of the TEAD inhibitor TYK-01054 capsules in patients with locally advanced or metastatic advanced solid tumors

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-01.

Trial Details

NCT Number	NCT07282873
Lead Sponsor	TYK Medicines, Inc
Conditions	Solid Tumor Malignancies, Malignant Mesothelioma (MM)
Enrollment	219 participants
Start Date	2026-01-01
Primary Completion	2028-01 (estimated)
Study Completion	2029-06 (estimated)
Updated on ClinicalTrials.gov	2025-12-22